Locally applied platelet-rich fibrin enhances healing of experimental tympanic membrane perforations in rats: an experimental study
- PMID: 40671152
- PMCID: PMC12269242
- DOI: 10.1186/s40001-025-02889-6
Locally applied platelet-rich fibrin enhances healing of experimental tympanic membrane perforations in rats: an experimental study
Abstract
Background: This study investigated the therapeutic efficacy of locally applied platelet-rich fibrin (PRF) on experimentally induced traumatic tympanic membrane perforations in rats.
Methods: The study comprised 24 young-adult Sprague Dawley rats (48 ears) randomly allocated into three groups of eight rats each: control group (no intervention), myringotomy group (standard perforation), and myringotomy with PRF application group. Otomicroscopic examinations were performed on days 7 and 14 to evaluate tympanic membrane healing and myringosclerosis development. Two rats from each experimental group were randomly selected for killing on day 7, with the remaining specimens collected on day 14. Histopathological analysis assessed acute and chronic inflammation, lamina propria edema and congestion, sclerosis, fibroblastic reaction, and squamous epithelial layer thickness.
Results: The PRF-treated group demonstrated superior healing outcomes compared to the myringotomy-only group. By day 14, complete tympanic membrane closure was achieved in all eight ears of the PRF group versus six of eight ears in the myringotomy group. Electrophysiological measurements revealed significantly improved signal-to-noise ratios in the PRF group, approaching normal levels by day 14 (p < 0.05). Histological examination showed reduced inflammation and better-organized tissue architecture in PRF-treated specimens.
Conclusion: PRF application significantly enhanced tympanic membrane healing, accelerated closure time, and improved histological outcomes in traumatic perforations. These findings suggest PRF represents a promising therapeutic option for traumatic tympanic membrane perforation repair, warranting further clinical investigation.
Keywords: Platelet-rich fibrin; Platelet-rich plasma; Tympanic membrane; Tympanic membrane perforation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval for this study was obtained from the Trakya University Ethics Committee for Animal Experiments (protocol code: 2023/18, decision number: 2023.10.03). The study was conducted in accordance with the ARRIVE guidelines 2.0. All experimental procedures involving animals were performed under strict ethical standards, and no human participants were involved in this research. Consent for publication: This study did not involve any human participants, human data, or human tissue. Competing interests: The authors declare no competing interests.
Figures



References
-
- Lou Z, Wang Y, Yu G. Effects of basic fibroblast growth factor dose on traumatic tympanic membrane perforation. Growth Factors. 2014;32(5):150–4. 10.3109/08977194.2014.952411. - PubMed
-
- Brown C, Behar P. Factors affecting persistent tympanic membrane perforation after tympanostomy tube removal in children. Int J Pediatr Otorhinolaryngol. 2020;130: 109779. 10.1016/j.ijporl.2019.109779. - PubMed
-
- Gökçe Kütük S, Özdaş T. Impact of platelet-rich fibrin therapy in tympanoplasty type 1 surgery on graft survival and frequency-specific hearing outcomes: a retrospective analysis in patients with tympanic membrane perforation due to chronic otitis media. J Laryngol Otol. 2019;133(12):1068–73. 10.1017/S0022215119002391. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources